Our founders believe that better and earlier diagnosis will result in much better health outcomes than the best therapeutics used at a later stage of a disease.

Leadership Team

Roya Khosravi-Far, PhD, PLD

President & Chief Executive Officer
Translational Medicine
Oncology & Infectious Diseases

Carlos Aparicio, Ph.D.

Chief Operating Officer
Medical Device Developer

Rich Devito, M.S.

Vice President of Engineering

Reza Mollaaghababa, Ph.D., J.D.

Chief Strategist

Outside Executives

Joe St. Germain

Outside CFO

Mike Rivard, J.D.

Outside Licensing
Corporate Legal
Business Development


Ariel Furst, Ph.D.

Assistant Professor
Chemical Engineering
Massachusetts Institute of Technology

Fatemeh Emdad, Ph.D.

Professor, Computer Science
Data Science
Worcester Polytechnic Institute

Clinical Collaborators

James Kirby, M.D., ABMM

Associate Professor, Pathology
Director of Clinical Microbiology
Harvard Medical School
Beth Israel Deaconess
Medical Center

Ramy Arnout, M.D., Ph.D.

Assistant Professor, Pathology
Clinical Informatics
Harvard Medical School
Beth Israel Deaconess
Medical Center

Stefan Riedel, M.D., Ph.D.

Associate Professor, Pathology
Medical & Public Health
Microbiology & Molecular Diagnostics
Beth Israel Deaconess Medical Center
Harvard Medical School

Strategic Advisors

Raphael Nir, Ph.D.

President and CSO
SBH Diagnostics

Barry Sands

President & Founder
Regulatory and Quality Management